Autosomal dominant osteopetrosis

被引:15
作者
Polgreen, Lynda E. [1 ,4 ]
Imel, Erik A. [2 ,3 ]
Econs, Michael J. [2 ]
机构
[1] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA USA
[2] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA
[3] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA
[4] 1124 W Carson St,Liu Res Bldg, Torrance, CA 90502 USA
关键词
Osteopetrosis; epidemiology; genetics; pathology; history; therapy; Genes; dominant; ALBERS-SCHONBERG-DISEASE; INTERFERON-GAMMA; CALCITRIOL; GENE; LOCALIZATION; THERAPY;
D O I
10.1016/j.bone.2023.116723
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant osteopetrosis (ADO) is the most common form of osteopetrosis. ADO is characterized by generalized osteosclerosis along with characteristic radiographic features such as a "bone-in-bone" appearance of long bones and sclerosis of the superior and inferior vertebral body endplates. Generalized osteosclerosis in ADO typically results from abnormalities in osteoclast function, due most commonly to mutations in the chloride channel 7 (CLCN7) gene. A variety of debilitating complications can occur over time due to bone fragility, impingement of cranial nerves, encroachment of osteopetrotic bone in the marrow space, and poor bone vascularity. There is a wide spectrum of disease phenotype, even within the same family. Currently, there is no disease specific treatment for ADO, so clinical care focuses on monitoring for disease complications and symp-tomatic treatment. This review describes the history of ADO, the wide disease phenotype, and potential new therapies.
引用
收藏
页数:4
相关论文
共 27 条
[1]   Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice [J].
Alam, Imranul ;
Gerard-O'Riley, Rita L. ;
Acton, Dena ;
Hardman, Sara L. ;
Murphy, Madeline ;
Alvarez, Marta B. ;
Blosser, Rachel J. ;
Sinn, Anthony ;
Srour, Edward F. ;
Kacena, Melissa A. ;
Econs, Michael J. .
FASEB JOURNAL, 2022, 36 (09)
[2]   Interferon Gamma, but not Calcitriol Improves the Osteopetrotic Phenotypes in ADO2 Mice [J].
Alam, Imranul ;
Gray, Amie K. ;
Acton, Dena ;
Gerard-O'Riley, Rita L. ;
Reilly, Austin M. ;
Econs, Michael J. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (11) :2005-2013
[3]  
Albers-Schonberg, 1904, Munch Med Wochenschr, V5, P365
[4]   Type II autosomal dominant osteopetrosis (Albers-Schonberg disease):: Clinical and radiological manifestations in 42 patients [J].
Bénichou, OD ;
Laredo, JD ;
De Vernejoul, MC .
BONE, 2000, 26 (01) :87-93
[5]  
BLAZAR BR, 1984, NEW ENGL J MED, V311, P55
[6]   RADIOLOGICAL, BIOCHEMICAL AND HEREDITARY EVIDENCE OF 2 TYPES OF AUTOSOMAL DOMINANT OSTEOPETROSIS [J].
BOLLERSLEV, J ;
ANDERSEN, PE .
BONE, 1988, 9 (01) :7-13
[7]   Intrafamilial phenotypic variability of osteopetrosis due to Chloride Channel 7 (CLCN7) mutations [J].
Campos-Xavier, AB ;
Casanova, JL ;
Doumaz, Y ;
Feingold, J ;
Munnich, A ;
Cormier-Daire, V .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 133A (02) :216-218
[8]   Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2 [J].
Capulli, Mattia ;
Maurizi, Antonio ;
Ventura, Luca ;
Rucci, Nadia ;
Teti, Anna .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 :1-13
[9]   The Erlenmeyer Flask Bone Deformity In the Skeletal Dysplasias [J].
Faden, Maha A. ;
Krakow, Deborah ;
Ezgu, Fatih ;
Rimoin, David L. ;
Lachman, Ralph S. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2009, 149A (06) :1334-1345
[10]   OXYGEN-DERIVED FREE-RADICALS STIMULATE OSTEOCLASTIC BONE-RESORPTION IN RODENT BONE INVITRO AND INVIVO [J].
GARRETT, IR ;
BOYCE, BF ;
OREFFO, ROC ;
BONEWALD, L ;
POSER, J ;
MUNDY, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :632-639